Dynamic Sr. Clinical Research Associate I at Fortrea, skilled in site monitoring and regulatory compliance. Proven ability to enhance team performance through effective training and leadership. Recognized for meticulous attention to detail, ensuring data integrity and patient safety in clinical trials. Committed to driving successful outcomes in diverse therapeutic areas.
Oncology: Solid Tumors – Breast (Phase I, II, III), Endocrine Tumors – Thyroid Cancer (Phase I, II, III), Gastro-intestinal Tumors – Colorectal (Phase I, II, III), Gastro-intestinal Tumors – Hepatocellular/liver (Phase I, II), Head and Neck – Squamous Cell Ca (Phase I, II, III), Melanoma (Loco-regional) (Phase I), Melanoma (Metastatic) (Phase I, II, III), Melanoma (PD-L1 expression) (Phase I), Thoracic Tumors -Non-Small Cell Lung Cancer (Phase I, II, III); Hematologic Malignancies – DLBCL (Phase I, II), non-Hodgkins Lymphoma (Phase I-II)
Microsoft Office (Excel, Outlook, Word, PowerPoint), Medidata Rave EDC,Bioclinica, Oracle Inform, Advarra, ALMAC
IRT Signant Health,Shared Investigator Portal, CTMS, VEEVA, Xcellerate RIM, Lablink, Acolad,Vestigo, Complion, Florence